The 4 Stages of Learning

Mar 24, 2020 | Blog | 0 comments

Daniel Gigante

Due to the coronavirus pandemic, many in the workforce are either working remotely or not working at all. This has presented them with unforeseen challenges. One which might initially seem innocuous, but could lead to damaging psychological effects, is boredom. With that in mind, we wanted to encourage people to level-up in their lives — be it professionally or personally.

One way to level-up faster is to understand the art of learning. Our very own Andrew Satz decided to sit down and discuss the 4 stages of learning. See below.

The 4 stages are fairly simple: luck, avoiding failure, learning from failure, learning from success.

The biggest takeaway is the importance of the 4th stage. It’s far too common for us to achieve a desired outcome and never evaluate how we could have improved our performance. However, if we don’t iterate, if we don’t improve, our next attempt may not result in the same outcome.

We hope you find this information useful. We will try to provide articles and videos that aren’t directly related to our business, but instead offer tips to improve or level-up both professionally and personally. Particularly, during these difficult times.


Submit a Comment

Your email address will not be published. Required fields are marked *

EVQLV and Manhattan BioSolutions Enter into Strategic Collaboration to Discover Novel Antibody-Based Therapies

The collaboration fuses EVQLV’s expertise in AI-enabled antibody design & Manhattan BioSolutions’ expertise in antibody development in oncology

Demystifying AI In Pharma

Examining AI as automated, assistive, analytical, accelerated, or augmented intelligence is a framework for thinking about how to apply these tools to data in ways that are aligned with an organization’s goals. This framework is designed to allow those who do not routinely build or employ AI to avoid the overhyped rhetoric of AI and consider the practical outcomes of employing it.

Andrew Satz on the Amplifying Scientific Innovation Podcast with Dr. Sophia Ononye-Onyia

EVQLV CEO, Andrew Satz, recently joined the Amplifying Scientific Innovation podcast with Dr. Sophia Ononye-Onyia. They discussed his definition of scientific innovation, personal anecdotes of his CEO journey and EVQLV’s unique approach to scientific innovation through the acceleration of biologic therapies with the power of artificial intelligence (A.I.).

How Our Algorithm Models the Drug Discovery Process

Our CEO, Andrew Satz, recently spoked at “Alumni in Conversation,” hosted by Columbia University School of General Studies. During the discussion, Andrew explained how EVQLV’s algorithm models the drug discovery process.

Large Pharma’s Embrace of Artificial Intelligence

The benefits of computational drug development are well known and accepted by many in the pharmaceutical space. However, since the onset of the global pandemic, consensus went from it being an interesting concept that was almost certainly the future, to something we need implemented as soon as possible. This is one of the few silver linings of the coronavirus outbreak.

Pin It on Pinterest